U.S. track & field athlete, Cabada, accepts finding of no fault for anti-doping rule violation
2 February 2017
USADA announced today that Fernando Cabada, of Lakewood, Colo., has tested positive for a prohibited substance, which was determined to have been ingested by him without fault or negligence.
Cabada, 34, tested positive for trace amounts of clenbuterol as the result of an out-of-competition urine sample he provided on December 6, 2016. Clenbuterol is an Anabolic Agent prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the International Association of Athletics Federations, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
Consistent with numerous prior reported cases globally, the issue of illicit administration of clenbuterol to animals destined for food production can result in, under specific conditions, a positive sample from an athlete. WADA has issued specific warnings about this problem in China and Mexico. To USADA’s knowledge, positive tests resulting from meat contamination issues are rare outside of those two countries. Moreover, due to strict regulatory and meat certification practices, USADA is not aware of any instances in which an athlete’s sample tested positive for clenbuterol after consumption of meat produced in the U.S.
During its investigation into the circumstances that led to the positive test, USADA gathered evidence from Cabada and reviewed Cabada’s whereabouts, dietary habits, and the laboratory reports demonstrating very low parts per billion concentrations of the prohibited substance in the athlete’s urine sample. USADA concluded that it was highly unlikely that the presence of clenbuterol in the athlete’s sample resulted from a source other than clenbuterol contaminated meat consumed in Mexico.
As a result, Cabada will not face a period of ineligibility for his positive test, and because the sample was collected out-of-competition, there are no competitive results to be disqualified.
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and psychoactive drugs. In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, including foreign athletes competing, training, or living in the U.S. USADA is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
- Tags: Anti-Doping | Athletics | Global DRO | United States of America (USA) | US Anti-Doping Agency (USADA) | USADA Protocol for Olympic and Paralympic Movement Testing | World Anti-Doping Agency (WADA)
- U.S. weightlifting athlete, Vrabel, accepts sanction for non-analytical anti-doping rule violation
- AAA arbitrator imposes four-year sanction on weightlifting athlete, Chan, for doping violation
- U.S. weightlifting athlete, Matsushima, accepts sanction for anti-doping rule violation
- U.S. handball athlete, Lamour, receives sanction for anti-doping rule violation